These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 35887159)
1. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease. Leo D; Targa G; Espinoza S; Villers A; Gainetdinov RR; Ris L Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887159 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices. Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164 [TBL] [Abstract][Full Text] [Related]
4. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity. Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926 [No Abstract] [Full Text] [Related]
5. Is there a role for biogenic amine receptors in mediating β-phenylethylamine and RO5256390-induced vascular contraction? Voisey AC; Broadley HD; Broadley KJ; Ford WR Eur J Pharmacol; 2024 Oct; 981():176895. PubMed ID: 39153650 [TBL] [Abstract][Full Text] [Related]
6. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease. Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864 [TBL] [Abstract][Full Text] [Related]
8. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain. Xie Z; Miller GM J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557 [TBL] [Abstract][Full Text] [Related]
9. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission. Alvarsson A; Zhang X; Stan TL; Schintu N; Kadkhodaei B; Millan MJ; Perlmann T; Svenningsson P J Neurosci; 2015 Oct; 35(41):14057-69. PubMed ID: 26468205 [TBL] [Abstract][Full Text] [Related]
10. TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease. Du Y; Fu M; Huang Z; Tian X; Li J; Pang Y; Song W; Tian Wang Y; Dong Z Aging Cell; 2020 Mar; 19(3):e13113. PubMed ID: 32061032 [TBL] [Abstract][Full Text] [Related]
11. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes. Xie Z; Westmoreland SV; Miller GM J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473 [TBL] [Abstract][Full Text] [Related]
13. Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders. Halff EF; Rutigliano G; Garcia-Hidalgo A; Howes OD Trends Neurosci; 2023 Jan; 46(1):60-74. PubMed ID: 36369028 [TBL] [Abstract][Full Text] [Related]
14. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640 [TBL] [Abstract][Full Text] [Related]
15. TAAR1 as an emerging target for the treatment of psychiatric disorders. Liu J; Wu R; Li JX Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862 [TBL] [Abstract][Full Text] [Related]
16. The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats. Ferragud A; Howell AD; Moore CF; Ta TL; Hoener MC; Sabino V; Cottone P Neuropsychopharmacology; 2017 Jun; 42(7):1458-1470. PubMed ID: 27711047 [TBL] [Abstract][Full Text] [Related]
17. T Tozzi F; Rutigliano G; Borsò M; Falcicchia C; Zucchi R; Origlia N Neurobiol Dis; 2021 Apr; 151():105271. PubMed ID: 33482355 [TBL] [Abstract][Full Text] [Related]
18. Recognition of methamphetamine and other amines by trace amine receptor TAAR1. Liu H; Zheng Y; Wang Y; Wang Y; He X; Xu P; Huang S; Yuan Q; Zhang X; Wang L; Jiang K; Chen H; Li Z; Liu W; Wang S; Xu HE; Xu F Nature; 2023 Dec; 624(7992):663-671. PubMed ID: 37935377 [TBL] [Abstract][Full Text] [Related]
19. Sigma-1 (σ₁) receptor deficiency reduces β-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B. Yin J; Sha S; Chen T; Wang C; Hong J; Jie P; Zhou R; Li L; Sokabe M; Chen L Neuropharmacology; 2015 Feb; 89():215-24. PubMed ID: 25286118 [TBL] [Abstract][Full Text] [Related]
20. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease. Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]